Mark Woodhams Promoted To Chief Revenue Officer

/PRNewswire/ — Accounting automation software leader BlackLine, Inc. (Nasdaq: BL) announced today that Mark Woodhams has been promoted to chief revenue… BlackLine SVP of global sales recognized for ability to scale sales and customer success organizations and expand global partner ecosystems LOS ANGELES , Jan. 6, 2021 /PRNewswire/ — Accounting automation software leader BlackLine , Inc. (Nasdaq: BL ) announced today...

READ MORE Mark Woodhams Promoted To Chief Revenue Officer

Press Release New Chairpersons 2021

The CRO Forum is pleased to announce that Allegra van Hövell-Patrizi, Chief Risk Officer of Aegon N.V., has been elected CRO Forum Chair for 2021. Allegra has been the Chief Risk Officer of Aegon N.V. since 2016. She has over 20 years’ experience in the financial services PRESS RELEASE NEW CHAIRPERSONS 2021 The CRO Forum is pleased to announce that...

READ MORE Press Release New Chairpersons 2021

Aura Announces Expansion of Leadership Team with CMO and CRO Hires

Press release content from PR Newswire. The AP news staff was not involved in its creation. BURLINGTON, Mass., Sept. 29, 2020 /PRNewswire/ — Aura , a technology company dedicated to simplifying digital security for consumers, today announced the appointment of industry leaders Dafna Sarnoff as Chief Marketing Officer and Christopher Bray as Chief Revenue Officer. The added leadership positions follow...

READ MORE Aura Announces Expansion of Leadership Team with CMO and CRO Hires

CNS Pharmaceuticals Engages CRO For Phase 2 Berubicin Clinical Trials

HOUSTON, Aug. 20, 2020 /PRNewswire/ — CNS Pharmaceuticals, Inc. (NASDAQ: CNSP[1]) (“CNS” or the “Company”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced it has engaged Worldwide Clinical Trials[2] (“Worldwide”) as the contract research organization (“CRO”) for its upcoming Berubicin clinical trials. Worldwide is a...

READ MORE CNS Pharmaceuticals Engages CRO For Phase 2 Berubicin Clinical Trials

Generated by Feedzy